nodes	percent_of_prediction	percent_of_DWPC	metapath
Eprosartan—hypertension—focal segmental glomerulosclerosis	0.463	1	CtDrD
Eprosartan—AGTR1—focal segmental glomerulosclerosis	0.368	1	CbGaD
Eprosartan—ABCC2—Cyclosporine—focal segmental glomerulosclerosis	0.0872	0.749	CbGbCtD
Eprosartan—CYP2C9—Cyclosporine—focal segmental glomerulosclerosis	0.0293	0.251	CbGbCtD
Eprosartan—AGTR1—nephron—focal segmental glomerulosclerosis	0.00678	0.402	CbGeAlD
Eprosartan—AGTR1—endothelium—focal segmental glomerulosclerosis	0.0032	0.189	CbGeAlD
Eprosartan—AGTR1—nephron tubule—focal segmental glomerulosclerosis	0.00146	0.0868	CbGeAlD
Eprosartan—Peripheral ischaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00143	0.0458	CcSEcCtD
Eprosartan—AGTR1—kidney—focal segmental glomerulosclerosis	0.00129	0.0762	CbGeAlD
Eprosartan—AGTR1—cortex of kidney—focal segmental glomerulosclerosis	0.00125	0.0743	CbGeAlD
Eprosartan—Losartan—AGTR1—focal segmental glomerulosclerosis	0.00119	0.551	CrCbGaD
Eprosartan—Myositis—Cyclosporine—focal segmental glomerulosclerosis	0.00106	0.0341	CcSEcCtD
Eprosartan—ABCC2—nephron tubule—focal segmental glomerulosclerosis	0.00106	0.0627	CbGeAlD
Eprosartan—ABCC2—kidney—focal segmental glomerulosclerosis	0.00093	0.0551	CbGeAlD
Eprosartan—Hypertriglyceridaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000906	0.0291	CcSEcCtD
Eprosartan—ABCC2—cortex of kidney—focal segmental glomerulosclerosis	0.000906	0.0537	CbGeAlD
Eprosartan—Serum creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.000846	0.0272	CcSEcCtD
Eprosartan—Blood triglycerides increased—Cyclosporine—focal segmental glomerulosclerosis	0.000794	0.0255	CcSEcCtD
Eprosartan—Influenza-like symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.000729	0.0234	CcSEcCtD
Eprosartan—Losartan—ACE—focal segmental glomerulosclerosis	0.000687	0.318	CrCbGaD
Eprosartan—Gingivitis—Cyclosporine—focal segmental glomerulosclerosis	0.000663	0.0213	CcSEcCtD
Eprosartan—Rigors—Cyclosporine—focal segmental glomerulosclerosis	0.000637	0.0205	CcSEcCtD
Eprosartan—Rhabdomyolysis—Cyclosporine—focal segmental glomerulosclerosis	0.000588	0.0189	CcSEcCtD
Eprosartan—Viral infection—Cyclosporine—focal segmental glomerulosclerosis	0.000576	0.0185	CcSEcCtD
Eprosartan—Arthropathy—Cyclosporine—focal segmental glomerulosclerosis	0.000572	0.0184	CcSEcCtD
Eprosartan—Herpes simplex—Cyclosporine—focal segmental glomerulosclerosis	0.000565	0.0181	CcSEcCtD
Eprosartan—Gout—Cyclosporine—focal segmental glomerulosclerosis	0.000557	0.0179	CcSEcCtD
Eprosartan—Influenza like illness—Cyclosporine—focal segmental glomerulosclerosis	0.000505	0.0162	CcSEcCtD
Eprosartan—Urinary incontinence—Cyclosporine—focal segmental glomerulosclerosis	0.000503	0.0161	CcSEcCtD
Eprosartan—Cramps of lower extremities—Cyclosporine—focal segmental glomerulosclerosis	0.000478	0.0153	CcSEcCtD
Eprosartan—Oesophagitis—Cyclosporine—focal segmental glomerulosclerosis	0.000476	0.0153	CcSEcCtD
Eprosartan—Urine output increased—Cyclosporine—focal segmental glomerulosclerosis	0.000471	0.0151	CcSEcCtD
Eprosartan—Abnormal vision—Cyclosporine—focal segmental glomerulosclerosis	0.000454	0.0146	CcSEcCtD
Eprosartan—Diabetes mellitus—Cyclosporine—focal segmental glomerulosclerosis	0.000434	0.0139	CcSEcCtD
Eprosartan—Polyuria—Cyclosporine—focal segmental glomerulosclerosis	0.00043	0.0138	CcSEcCtD
Eprosartan—Gastroenteritis—Cyclosporine—focal segmental glomerulosclerosis	0.000426	0.0137	CcSEcCtD
Eprosartan—Vascular purpura—Cyclosporine—focal segmental glomerulosclerosis	0.000422	0.0136	CcSEcCtD
Eprosartan—Eczema—Cyclosporine—focal segmental glomerulosclerosis	0.00042	0.0135	CcSEcCtD
Eprosartan—Hot flush—Cyclosporine—focal segmental glomerulosclerosis	0.000404	0.013	CcSEcCtD
Eprosartan—Menopausal symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.0004	0.0129	CcSEcCtD
Eprosartan—Purpura—Cyclosporine—focal segmental glomerulosclerosis	0.000392	0.0126	CcSEcCtD
Eprosartan—Arthritis—Cyclosporine—focal segmental glomerulosclerosis	0.000389	0.0125	CcSEcCtD
Eprosartan—Cardiac failure—Cyclosporine—focal segmental glomerulosclerosis	0.000387	0.0124	CcSEcCtD
Eprosartan—Osteoarthritis—Cyclosporine—focal segmental glomerulosclerosis	0.000378	0.0121	CcSEcCtD
Eprosartan—Migraine—Cyclosporine—focal segmental glomerulosclerosis	0.000372	0.0119	CcSEcCtD
Eprosartan—Blood creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.000354	0.0114	CcSEcCtD
Eprosartan—Gastritis—Cyclosporine—focal segmental glomerulosclerosis	0.000334	0.0107	CcSEcCtD
Eprosartan—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.000333	0.0107	CcSEcCtD
Eprosartan—Sweating increased—Cyclosporine—focal segmental glomerulosclerosis	0.000318	0.0102	CcSEcCtD
Eprosartan—Bronchitis—Cyclosporine—focal segmental glomerulosclerosis	0.000314	0.0101	CcSEcCtD
Eprosartan—Upper respiratory tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.000303	0.00974	CcSEcCtD
Eprosartan—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.000302	0.00968	CcSEcCtD
Eprosartan—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000295	0.00945	CcSEcCtD
Eprosartan—Depression—Cyclosporine—focal segmental glomerulosclerosis	0.00029	0.00932	CcSEcCtD
Eprosartan—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.000286	0.00919	CcSEcCtD
Eprosartan—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.000285	0.00916	CcSEcCtD
Eprosartan—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.000283	0.00908	CcSEcCtD
Eprosartan—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.000283	0.00908	CcSEcCtD
Eprosartan—Losartan—ALB—focal segmental glomerulosclerosis	0.000282	0.13	CrCbGaD
Eprosartan—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.000278	0.00891	CcSEcCtD
Eprosartan—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.000275	0.00881	CcSEcCtD
Eprosartan—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.000273	0.00877	CcSEcCtD
Eprosartan—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.000262	0.00841	CcSEcCtD
Eprosartan—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.000259	0.00833	CcSEcCtD
Eprosartan—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.000252	0.00808	CcSEcCtD
Eprosartan—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.000244	0.00782	CcSEcCtD
Eprosartan—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.000234	0.00753	CcSEcCtD
Eprosartan—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.000224	0.0072	CcSEcCtD
Eprosartan—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.000223	0.00717	CcSEcCtD
Eprosartan—AGTR1—ACE Inhibitor Pathway—AGTR2—focal segmental glomerulosclerosis	0.000222	0.141	CbGpPWpGaD
Eprosartan—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.000221	0.00709	CcSEcCtD
Eprosartan—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.000219	0.00702	CcSEcCtD
Eprosartan—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.000213	0.00684	CcSEcCtD
Eprosartan—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000211	0.00678	CcSEcCtD
Eprosartan—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.000208	0.00667	CcSEcCtD
Eprosartan—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.000205	0.00659	CcSEcCtD
Eprosartan—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.000204	0.00656	CcSEcCtD
Eprosartan—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.000199	0.00637	CcSEcCtD
Eprosartan—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.000194	0.00622	CcSEcCtD
Eprosartan—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.000194	0.00622	CcSEcCtD
Eprosartan—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.000194	0.00622	CcSEcCtD
Eprosartan—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.000193	0.0062	CcSEcCtD
Eprosartan—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000191	0.00614	CcSEcCtD
Eprosartan—AGTR1—ACE Inhibitor Pathway—ACE—focal segmental glomerulosclerosis	0.00019	0.12	CbGpPWpGaD
Eprosartan—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.000189	0.00608	CcSEcCtD
Eprosartan—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000182	0.00584	CcSEcCtD
Eprosartan—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.000179	0.00576	CcSEcCtD
Eprosartan—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.000177	0.00568	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000169	0.00543	CcSEcCtD
Eprosartan—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.000168	0.00539	CcSEcCtD
Eprosartan—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000167	0.00535	CcSEcCtD
Eprosartan—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.000166	0.00531	CcSEcCtD
Eprosartan—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.000165	0.0053	CcSEcCtD
Eprosartan—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.000163	0.00525	CcSEcCtD
Eprosartan—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.000161	0.00518	CcSEcCtD
Eprosartan—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.00016	0.00514	CcSEcCtD
Eprosartan—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.000159	0.0051	CcSEcCtD
Eprosartan—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.000159	0.0051	CcSEcCtD
Eprosartan—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.000153	0.00491	CcSEcCtD
Eprosartan—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000152	0.00487	CcSEcCtD
Eprosartan—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.000147	0.00473	CcSEcCtD
Eprosartan—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000147	0.00471	CcSEcCtD
Eprosartan—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.000147	0.00471	CcSEcCtD
Eprosartan—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.000137	0.00439	CcSEcCtD
Eprosartan—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.000133	0.00428	CcSEcCtD
Eprosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—ANGPT2—focal segmental glomerulosclerosis	0.000131	0.0835	CbGpPWpGaD
Eprosartan—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000131	0.00422	CcSEcCtD
Eprosartan—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000127	0.00408	CcSEcCtD
Eprosartan—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000123	0.00394	CcSEcCtD
Eprosartan—AGTR1—ACE Inhibitor Pathway—AGT—focal segmental glomerulosclerosis	0.00012	0.0763	CbGpPWpGaD
Eprosartan—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000118	0.00379	CcSEcCtD
Eprosartan—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000117	0.00376	CcSEcCtD
Eprosartan—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000117	0.00375	CcSEcCtD
Eprosartan—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000116	0.00373	CcSEcCtD
Eprosartan—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.00011	0.00354	CcSEcCtD
Eprosartan—AGTR1—Arf6 signaling events—GNAQ—focal segmental glomerulosclerosis	0.000105	0.0665	CbGpPWpGaD
Eprosartan—AGTR1—Peptide GPCRs—AGTR2—focal segmental glomerulosclerosis	6.85e-05	0.0435	CbGpPWpGaD
Eprosartan—AGTR1—ACE Inhibitor Pathway—TGFB1—focal segmental glomerulosclerosis	5.83e-05	0.037	CbGpPWpGaD
Eprosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—FN1—focal segmental glomerulosclerosis	4.68e-05	0.0297	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—CD40LG—focal segmental glomerulosclerosis	4.19e-05	0.0266	CbGpPWpGaD
Eprosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—MMP2—focal segmental glomerulosclerosis	3.97e-05	0.0252	CbGpPWpGaD
Eprosartan—AGTR1—G alpha (q) signalling events—TRPC6—focal segmental glomerulosclerosis	3.28e-05	0.0208	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—AGTR2—focal segmental glomerulosclerosis	3.22e-05	0.0204	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—focal segmental glomerulosclerosis	2.93e-05	0.0186	CbGpPWpGaD
Eprosartan—AGTR1—G alpha (q) signalling events—GNAQ—focal segmental glomerulosclerosis	2.74e-05	0.0174	CbGpPWpGaD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—AGTR2—focal segmental glomerulosclerosis	2.52e-05	0.016	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—GNAQ—focal segmental glomerulosclerosis	2.45e-05	0.0156	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—AGTR2—focal segmental glomerulosclerosis	2.16e-05	0.0137	CbGpPWpGaD
Eprosartan—AGTR1—G alpha (q) signalling events—EDN1—focal segmental glomerulosclerosis	2.13e-05	0.0135	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—EDN1—focal segmental glomerulosclerosis	2.1e-05	0.0133	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—focal segmental glomerulosclerosis	1.9e-05	0.0121	CbGpPWpGaD
Eprosartan—AGTR1—G alpha (q) signalling events—AGT—focal segmental glomerulosclerosis	1.76e-05	0.0112	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—AGT—focal segmental glomerulosclerosis	1.74e-05	0.0111	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—TGFB1—focal segmental glomerulosclerosis	1.71e-05	0.0108	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	1.64e-05	0.0104	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—focal segmental glomerulosclerosis	1.58e-05	0.01	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	1.41e-05	0.00894	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	1.17e-05	0.00742	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	1.07e-05	0.00681	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	9.35e-06	0.00594	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	9.3e-06	0.0059	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	8.9e-06	0.00565	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	8.78e-06	0.00558	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	8.49e-06	0.00539	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	8.44e-06	0.00536	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	8.07e-06	0.00513	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	7.99e-06	0.00508	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	7.82e-06	0.00496	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	7.1e-06	0.00451	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	6.82e-06	0.00433	CbGpPWpGaD
Eprosartan—ABCC2—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	6.52e-06	0.00414	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	6.06e-06	0.00385	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	5.5e-06	0.00349	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	5.03e-06	0.00319	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	5.02e-06	0.00318	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	4.99e-06	0.00317	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	4.57e-06	0.0029	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	4.19e-06	0.00266	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	3.81e-06	0.00242	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	3.35e-06	0.00213	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	3.3e-06	0.0021	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	3.25e-06	0.00206	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	3.15e-06	0.002	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.99e-06	0.0019	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.7e-06	0.00171	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.49e-06	0.00158	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	2.32e-06	0.00147	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.07e-06	0.00132	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	1.99e-06	0.00126	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—LIPC—focal segmental glomerulosclerosis	1.69e-06	0.00108	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.59e-06	0.00101	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	1.52e-06	0.000968	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CTGF—focal segmental glomerulosclerosis	1.49e-06	0.000947	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.37e-06	0.000873	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.31e-06	0.000832	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—LPL—focal segmental glomerulosclerosis	1.03e-06	0.000657	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—AGT—focal segmental glomerulosclerosis	8.85e-07	0.000562	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ALB—focal segmental glomerulosclerosis	6.79e-07	0.000431	CbGpPWpGaD
